| [1] Rudy J Castellani, Raj K Rolston, Mark A Smith. Alzheimer’s disease [J]. Dis Mon, 2010, 56(9):484–546. [2] Victor W. Henderson. Aging, estrogens, and episodic memory in women [J]. Cogn Behav Neurol, 2009, 22(4): 205–214.[3] Barbara B Sherwin. Estrogen and cognitive aging in women [J]. Trends Pharmacol Sci, 2002, 23(11):527–534. [4] Robert D Brinton. Impact of estrogen therapy on Alzheimer’s disease: a fork in the road? [J]. CNS Drugs, 2004, 18(7):405–422.[5] Christian J Pike, Jenna C Carroll, Emily R Rosario, et al. Protective actions of sex steroid hormones in Alzheimer’s disease [J]. Front Neuroendocrinol, 2009, 30(2): 239–258[6] Tonita E Wroolie, Heather A Kenna, Katherine E Williams, et al. Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens [J]. Am J Geriatr Psychiatry, 2011, 19(9): 792–802.[7] Xu Jinping, Monina Bartoces, Anne Victoria Neale, et al. Natural history of menopause symptoms in primary care patients: a metro net study [J].J Am Board Fam Pract, 2005, 18(5):374–382.[8] Oliver Kretz, Lars Fester, Uwe Wehrenberg, et al. Hippocampal synapses depend on hippocampal estrogen synthesis [J].J Neurosci, 2004, 24(26):5913–5921. [9] Yasushi Hojo, Gen Murakami, Hideo Mukai, et al. Estrogen synthesis in the brain-role in synaptic plasticity andmemory[J]. Mol Cell Endocrinol, 2008, 290(1-2):31–43. [10] Teresa A Milner, Kehinde Ayoola, Carrie T Drake, et al. Ultrastructural localization of estrogen receptor beta immunoreactivity in the rat hippocampal formation[J]. J Comp Neurol, 2005, 491(2):81–95. [11] Shughrue PJ, Scrimo PJ, Merchenthaler I. Estrogen binding and estrogen receptor characterization (ERα and ERβ) in the cholinergic neurons of the rat basal forebrain[J]. Neuroscience, 2000, 96(1):41–49. [12] Dean P Edwards. Regulation of signal transduction pathways by estrogen and progesterone [J]. Annu Rev Physiol, 2005, 67:335–376.[13] Giovanni Pagano, Giuseppe Castello. Oxidative stress and mitochondrial dysfunction in down syndrome [J]. Adv Exp Med Biol, 2012, 724:291-299.[14] 周晓雯,苏朝芬,罗焕敏.线粒体与神经退行性疾病[J].神经药理学报, 2011, 1（3）:41-46[15] Verri M, Pastoris O, Dossena M, et al. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer’s disease[J]. Int J Immunopathol Pharmacol, 2012, 25(2):345-353.[16] Paula I Moreira, Maria S Santos, Raquel Seica, et al. Brain mitochondrial dysfunction as a link between Alzheimer’s diseaseand diabetes[J]. J Neurol Sci, 2007, 257(1-2):206–214.[17] Jiong Shi, James W Simpkins. 17 beta-Estradiol modulation of glucose transporter 1 expression in blood-brain barrier [J]. Am J Physiol, 1997, 272 (6 Pt 1):E1016-1022. [18] Clara M Cheng, Matt Cohen, Jie Wang, et al. Estrogen augments glucose transporter and IGF1expression in primate cerebral cortex[J]. Faseb J, 2001,15(6):907–915. [19] Simpkins JW, Wang J, Wang X, et al. Mitochondria play a central role in estrogen-induced neuroprotection[J]. Curr Drug Targets CNS Neurol Disord, 2005, 4(1):69–83.[20] Jon Nilsen, Chen Shuhua, Ronald W Irwin, et al. Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function[J]. BMC Neurosci, 2006, 7(3):74-88.[21] James W Simpkins, Yi Kun-don, Yang Shao-hua, et al. Mitochondrial mechanisms of estrogen neuroprotection[J].Biochim Biophys Acta, 2010, 1800(10):1113-1120[22] Kostanyan A, Nazaryan K. Rat brain glycolysis regulation by estradiol-17beta [J]. Biochim Biophys Acta, 1992, 1133(3):301–306.[23] Clara M Cheng, Matt Cohen, Jie Wang, et al. Estrogen augments glucose transporter and IGF-1expression in primate cerebral cortex[J]. Faseb J, 2001, 15(6):907–915.[24] Pablo Mendez, Francisco Wandosell, Luis M Garcia-Segura. Cross-talk between estrogen receptors and insulinlike growth factor-I receptor in the brain: cellular and molecular mechanisms [J]. Front Neuroendocrinol, 2006, 27(4):391–403.[25] Pablo Mendez, Luis Miguel Garcia-Segura. Phosphatidylinositol 3-kinase and glycogen synthase kinase 3 regulate estrogen receptor-mediated transcription in neuronal cells [J]. Endocrinology, 2006, 147(6):3027–3039. [26] Gloria P Cardona-Gomez, Pablo Mendez, Lydia L Don Carlos, et al. Interactions of estrogen and insulin-like growth factor-I in the brain: molecular mechanisms and functional implications[J]. J Steroid Biochem Mol Biol, 2002, 83(1-5):211–217. [27] Luis Miguel Garcia-Segura, Gloria Patrica Cardona-Gomez, Julie Ann Chowen, et al. Insulin-like growth factor-Ireceptors and estrogen receptors interact in the promotion of neuronal survival and neuroprotection [J]. J Neurocytol, 2000, 29(5-6):425–437.[28] Carro E, Trejo JL, Gomez-Isla T, et al. Serum insulin-like growth factor Iregulates brain amyloid-beta levels[J]. Nat Med, 2002, 8(12):1390–1397.[29] Pauline M Maki, Susan M Resnick. Longitudinal effects of estrogen replacement therapy on PET cerebralblood flow and cognition [J]. Neurobiol Aging, 2000, 21(2):373–383. [30] Natalie L Rasgon, Daniel Silverman, Prabha Siddarth, et al. Estrogen use and brain metabolic change in postmenopausal women[J].Neurobiol Aging, 2005, 26(2):229–235. [31] Winnie S Liang, Eric M Reiman, Jon Valla, et al. Alzheimer’s disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons[J]. Proc Natl Acad Sci USA, 2008, 105(11):4441–4446. [32] 孙爱华,姜颖, 贺福初.线粒体蛋白质表达谱的研究进展[J].遗传, 2006, 28(10): 1311-1315,[33] Jon Nilsen, Ronald W Irwin, Timothy K Gallaher, et al. Estradiol in vivo regulation of brain mitochondrial proteome[J]. J Neurosci, 2007, 27(51):14069–14077. [34] Roberta D Brinton, Chen Shu-hua, Marissa Montoya, et al. The women’s health initiative estrogen replacement therapy is neurotrophic and neuroprotective[J]. Neurobiol Aging, 2000, 21(3):475–496.[35] Lina Holmquist, Grant Stuchbury, Katrin Berbaum, et al. Lipoic acid as a novel treatment for Alzheimer’s disease and related dementias[J]. Pharmacol Ther, 2007, 113(1):154–164.[36] Chris Stirone, Sue P Duckles, Diana N Krause, et al. Estrogen increases mitochondrial efficiency andreduces oxidative stress in cerebral blood vessels[J]. Mol Pharmacol, 2005, 68(4):959–965.[37] Michael T. Lin, M.Flint Beal. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases [J].Nature, 2006, 443(7113):787–795. [38] Parvesh Bubber, Vahram Haroutunian, Gene Fisch, et al. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications [J]. Ann Neurol, 2005, 57(5):695–703. [39] Eric A Sribnick, Angelo M Del Re, Swapan K Ray, et al. Estrogen attenuates glutamate-induced cell death by inhibiting Ca2+ influx through L-type voltage-gated Ca2+ channels[J]. Brain Res, 2009, 18(1276):159-170.[40] Jon Nilsen, Roberta Diaz Brinton. Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression[J]. Proc Natl Acad Sci USA, 2003, 100(5):2842–2847.[41] Nilsen J, Brinton RD. Mitochondria as therapeutic targets of estrogen action in the central nervous system [J]. Curr Drug Targets CNS Neurol Disord, 2004, 3(4):297–313. [42] John H Morrison, Roberta D Brinton, Peter J Schmidt, et al. Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women [J]. J Neurosci, 2006, 26(41):10332–10348 |
